Ticker LaunchIPO · NRIX
Nurix Therapeutics, Inc.
Formerly Nurix, Inc.
Nurix Therapeutics, Inc. (NRIX) priced its initial public offering on Jul 24, 2020 at $19.00 per share, above its $17.00–$18.00 range, raising $209M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $703.7M. J.P. Morgan was lead-left underwriter, joined by Piper Sandler, Stifel and Needham. Davis Polk advised the underwriters.
- Status
- IPO
- Ticker
- NRIX
- Exchange
- Nasdaq Global Market
- Priced
- Jul 24, 2020
- IPO price
- $19.00
- Price range
- $17.00–$18.00
- Raised
- $209M
- Market cap at IPO price
- $703.7M
- First filed
- Jul 2, 2020
- Underwriters
- J.P. Morgan, Piper Sandler, Stifel and Needham
- Underwriters' counsel
- Davis Polk
- Sector
- Biotech & pharma
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jul 2, 2020
- Latest amendment Jul 23, 2020
- Final prospectus (424B4) Jul 24, 2020
- All filings on EDGAR CIK 1549595
Other Biotech & pharma IPOs in 2020
- Kalaris Therapeutics, Inc.ALVR · Jul 30, 2020 · $276.2M
- iTeos Therapeutics, Inc.ITOS · Jul 27, 2020 · $201.1M
- Annexon, Inc.ANNX · Jul 24, 2020 · $250.8M
- Inozyme Pharma, Inc.Jul 24, 2020 · $112M
- ALX Oncology Holdings IncALXO · Jul 17, 2020 · $161.5M
- Pandion Therapeutics, Inc.PAND · Jul 17, 2020 · $135M